Every health product provides benefits but also poses risks. This is referred to as the “benefit-risk balance”. Our mission is to ensure that this balance is positive, i.e. that the benefits to the patient are greater than the risks.
This applies from the therapeutic innovation development stage.
In this way, in the aim of facilitating safe access for patients to innovative products, ANSM intervenes in various ways to support innovation and oversee measures to ensure its early, safe, and fair implementation.
We also support the development of paediatric medicines.
This applies from the therapeutic innovation development stage.
In this way, in the aim of facilitating safe access for patients to innovative products, ANSM intervenes in various ways to support innovation and oversee measures to ensure its early, safe, and fair implementation.
We also support the development of paediatric medicines.
